These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33899786)

  • 1. Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung.
    Agaimy A; Stoehr R; Michal M; Christopoulos P; Winter H; Zhang L; Stenzinger A; Michal M; Mechtersheimer G; Antonescu CR
    Am J Surg Pathol; 2021 Nov; 45(11):1541-1549. PubMed ID: 33899786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell stromal tumour of the lung with YAP1::TFE3 fusion: four cases including a case with highly aggressive clinical course.
    Dehner CA; Sadegh D; Boulos F; Messias N; Wang WL; Demicco EG; Chrisinger JSA
    Histopathology; 2022 Aug; 81(2):239-245. PubMed ID: 35762906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1-TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity.
    Dermawan JK; Azzato EM; McKenney JK; Liegl-Atzwanger B; Rubin BP
    Histopathology; 2021 Dec; 79(6):940-946. PubMed ID: 34156713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell stromal tumor of the lung with multinucleated giant cells: a report of a case with YAP1-TFE3 fusion.
    Jakša R; Stružinská I; Kendall Bártů M; Trča S; Matěj R; Dundr P
    Diagn Pathol; 2023 Jan; 18(1):9. PubMed ID: 36707859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
    Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
    Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
    Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
    Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
    Antonescu CR; Le Loarer F; Mosquera JM; Sboner A; Zhang L; Chen CL; Chen HW; Pathan N; Krausz T; Dickson BC; Weinreb I; Rubin MA; Hameed M; Fletcher CD
    Genes Chromosomes Cancer; 2013 Aug; 52(8):775-84. PubMed ID: 23737213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
    Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
    Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
    Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
    APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
    Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
    Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour.
    Kojima N; Nishino S; Sasahara Y; Taki T; Imada H; Miyoshi T; Watanabe SI; Ishii G; Yatabe Y; Mori T; Yoshida A
    Histopathology; 2024 Sep; ():. PubMed ID: 39327855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
    Anderson WJ; Fletcher CDM; Hornick JL
    Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3 -Rearranged PEComa/PEComa-like Neoplasms : Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy.
    Argani P; Gross JM; Baraban E; Rooper LM; Chen S; Lin MT; Gocke C; Agaimy A; Lotan T; Suurmeijer AJH; Antonescu CR
    Am J Surg Pathol; 2024 Jul; 48(7):777-789. PubMed ID: 38597260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
    Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.
    Ohe C; Kuroda N; Hes O; Michal M; Vanecek T; Grossmann P; Tanaka Y; Tanaka M; Inui H; Komai Y; Matsuda T; Uemura Y
    Med Mol Morphol; 2012 Dec; 45(4):234-7. PubMed ID: 23224603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant.
    Puls F; Niblett A; Clarke J; Kindblom LG; McCulloch T
    Virchows Arch; 2015 Apr; 466(4):473-8. PubMed ID: 25680571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
    Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
    Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.